scorecardresearch
Add as a preferred source on Google
Tuesday, March 31, 2026
HomeHealth

Health

As GLP-1 generics flood Indian market, drug regulator cracks down on illegal sale & misleading ads

The push follows the patent expiry of semaglutide, which set off a rush of cheaper generics, but also exposed regulatory gaps—particularly in digital pharmacies and clinics.

NEET-PG cut-off reduction didn’t alter merit, only expanded pool—Centre reiterates stand in SC

The affidavit is the government's third submission to the SC in response to a writ petition filed by social worker Harisharan Devgan & others challenging the January cut-off revision.

‘Price no challenge, mindset is’: Novo Nordisk eyes next-gen anti-obesity drugs as generics enter market

Nordisk’s India managing director told ThePrint, his company has now moved to higher-dose Semaglutide, oral formulations and two new therapies which are advancing as cardiometabolic care.

Yes or no to front-of-pack warning labels? Industry, consumer groups dig their heels in at FSSAI meet

Warning-style labels are 'overly simplistic' & could mislead or alarm consumers, say industry voices. Consumer groups say industry views dominated talks, and a basic health measure meant to inform the public is being avoided.

Why do women make up two-thirds of Alzheimer’s cases? Study links risk to hormonal changes in midlife

New research published in The Journal of Clinical Investigation argues that Alzheimer’s may begin much earlier than previously thought, often between the ages of 45 and 65.

FSSAI seeks more time from SC to work on front-of-pack labels for foods with high fat, sugar & salt

Food regulator FSSAI weighs pictures versus labels on packaged food amid growing pressure for long-overdue health reform.

Why new guidelines in US recommend screening for ‘bad cholesterol’ as early as ages 9-11

Guidelines by American College of Cardiology, American Heart Association & other organisations endorse early detection and treatment of dyslipidemia—unhealthy levels of fats in blood.

Gross underspend cripples India’s community-level mental health battle. States spent 50% funds for 5 yrs

States have consistently underspent funds under District Mental Health Programme, which involves OPD, community outreach, awareness & training of healthcare workers in districts. 

Study links heavy metals, ‘hidden drugs’ in alt meds to liver injury. Safety, regulation debate grows

Kerala researchers study 386 products, covering Ayurveda, Homoeopathy, Siddha, Unani, other traditional remedies. Findings raise concerns about regulatory oversight of Ayush meds.

Why US drugmaker Eli Lilly is warning against compounded tirzepatide mixed with vitamin B12

Tirzepatide is the active ingredient in Lilly’s popular anti-obesity & diabetes drugs, Mounjaro & Zepbound. Experts say the matter has little relevance for India at present.

On Camera

How West Asia crisis can play out for PM Modi and BJP in Assembly polls

While the Russia-Ukraine war saw the BJP projecting PM Modi as a ‘vishwaguru’ who could end international conflicts, the party has made a nuanced shift in its electoral strategy vis-à-vis the West Asia war.

Foreign investors dump record $12 bn India stocks in March on war

Soaring energy costs have hurt oil-importing Asian peers, but the scale of outflows from India points to already bearish global sentiment.

India developing lethal autonomous weapon systems, database of citizens’ crime risk—House Panel report

Report on impact of AI emergence—drawing upon depositions from several ministries—confirms that the developments come in the absence of AI laws or considerations over them.

Gulf war exposed India’s fragilities. It’s time for navel-gazing, in the national interest

It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.